Skip to content

Sarah Khozema Hussain Azad, MD

NPI 1194335158ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Omaha, NE

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Omaha, Nebraska, licensed in NE and NY, with an NPI issued in August 2020. Part D covered 140 prescriptions written in 2024, 45% of them generic. Abbvie Inc. reported $17.28 in payments in 2025, mostly food and beverage.

Overview

NPI1194335158
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedAug 5, 2020
Last updated in NPPESSep 29, 2025
Certified by providerSep 29, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (NY)

Part D prescriptions in 2024

Prescriptions (claims)140 · 248 30-day fills
Patients35
Total drug cost$36,735
Generic share45% of claims

Medicare sources and data years

Education and affiliations

Graduation year2019
Medicare specialtyEndocrinology

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$17.28 · 1 payment from 1 company
  • 2024$182.73 · 3 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Abbvie Inc.$17.281

What the 2025 payments were for

  • Food and Beverage$17.28 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Omaha

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Nebraska →